Elon Musk Loses OpenAI Lawsuit; Colossal Biosciences Unveils Artificial Egg Breakthrough

Breaking News

Elon Musk has lost his landmark lawsuit against OpenAI, with a federal judge ruling that the company’s shift to a for-profit model did not violate its original nonprofit mission. The decision ends a high-profile legal battle that pitted Musk against OpenAI cofounders Sam Altman and Greg Brockman.

Simultaneously, Colossal Biosciences announced it has developed a “fully artificial egg”—a 3D-printed plastic shell that can incubate chicken embryos to hatching. The breakthrough is part of the company’s effort to resurrect extinct bird species like the dodo and the giant moa.

Both developments, reported Tuesday, underscore the rapid pace of innovation—and controversy—in biotech and artificial intelligence.

Musk v. Altman: What the Court Decided

Elon Musk alleged that Altman and Brockman misled him about OpenAI’s commitment to open-source, nonprofit goals when he invested. The court disagreed, citing evidence that OpenAI’s mission evolved as the company scaled.

“The ruling reaffirms that mission statements can adapt without fraud,” said Michelle Kim, AI reporter and attorney who covered the trial for MIT Technology Review. “Musk failed to prove intentional deception.”

Kim joined editor in chief Mat Honan in an exclusive Roundtables discussion to unpack the implications. Subscribers can access the full recording.

Artificial Egg: Science or Hype?

Colossal Biosciences’ “fully artificial egg” is a transparent 3D-printed plastic cup that replaces the natural shell. The company claims it successfully hatched chicks from this artificial environment, a step toward resurrecting extinct avian species.

“This is a notable technical feat, but not a true artificial egg,” said Dr. Sarah J. O’Brien, a reproductive biologist at University of Cambridge. “It lacks the dynamic exchange of nutrients and gases that a real shell provides.”

Some scientists question whether the technology can scale to resurrect the dodo. Colossal, however, views it as an early step toward artificial wombs—potentially revolutionizing conservation and animal breeding.

Background

OpenAI Lawsuit

Musk cofounded OpenAI in 2015 as a nonprofit to develop AI safely. When the company pivoted to a for-profit structure, Musk resigned and later sued, claiming betrayal. The trial lasted weeks and featured testimony from top AI executives.

Artificial Egg Research

Colossal Biosciences is known for gene-editing projects to revive the woolly mammoth. The artificial egg project leverages 3D printing and custom incubation chambers to mimic avian development outside the natural egg. The company’s Dallas headquarters displayed the hatching chicks in clear cups.

The research was reported by Antonio Regalado of MIT Technology Review. Some experts remain skeptical of the company’s claims, but acknowledge the potential for advancing reproductive technology.

What This Means

For AI regulation: The Musk v. Altman verdict may set a precedent that for-profit AI companies can evolve from nonprofit origins without legal liability. This could encourage more startups to pivot for commercial viability.

For biotechnology: The artificial egg could eventually reduce the need for natural eggs in conservation and poultry farming. If combined with gene drives, it might enable the restoration of extinct species—but ethical and technical hurdles remain.

“We are still decades away from a true artificial womb,” said Dr. O’Brien. “But each step, like this artificial egg, brings us closer to rethinking reproduction itself.”

—Reporting by MIT Technology Review staff